论文部分内容阅读
目的用中西医结合的方法观察抵克力得 (Ticlopidine)与川芎嗪联合治疗缺血性脑血管病的临床疗效。方法将 5 2例病人 ,男 2 8例 ,女 2 4例分为两组 ,治疗组 32例 ,对照组 2 0例 ,治疗组Ticlopidine 2 5 0mgqd ,川芎嗪 80～ 140mg divgttqd ,1个月为 1个疗程。对照组单用Ticlopidine 2 5 0mgqd。结果治疗组总有效率优于对照组 (P <0 0 5 ) ,1年后复发率治疗组 12 5 % ,对照组 30 % ,低于国内大宗病例与阿斯匹林的比较。结论中西医结合治疗缺血性脑血管病优于单用Ticolpidine的治疗 ,两者联合应用 ,既预防又治疗 ,两者兼顾。
Objective To observe the clinical efficacy of combination of Ticlopidine and ligustrazine in the treatment of ischemic cerebrovascular disease with the method of integrated traditional Chinese and western medicine. Methods A total of 52 patients, 28 males and 24 females, were divided into two groups. The treatment group (32 cases) and the control group (20 cases) were treated with Ticlopidine 250 mg qd and ligustrazine 80 ~ 140 mg divgttqd for one month 1 course of treatment. The control group alone Ticlopidine 250mgqd. Results The total effective rate of the treatment group was better than that of the control group (P <0.05). The recurrence rate after 1 year was 125% in the treatment group and 30% in the control group, which was lower than that in the domestic large cases and aspirin. Conclusion Integrative treatment of ischemic cerebrovascular disease is better than single Ticolpidine treatment, the combination of the two, both prevention and treatment, both.